Stan Gronthos
University of Adelaide, SA, Australia
- This delegate is presenting an abstract at this event.
Stan Gronthos is Professor of Stem Cell Biology and Regenerative Medicine, and Founder and Head of the Mesenchymal Stem Cell Laboratory, Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide. He is a Senior Principal Research Fellow of the South Australian Health and Medical Research Institute Faculty, and a Fellow of the American Society of Bone and Mineral Research. He has co-authored over 206 publications with over 37,500 citations (Google Scholar, H factor = 75) and 13 patents describing the composition of matter and application of purified postnatal human mesenchymal stem cells derived from bone marrow, adipose tissue, and dental tissue. His stem cell patent family was the foundation intellectual property for the formation of Mesoblast Ltd., one of the world’s largest regenerative medicine based companies, which is currently sponsoring multiple human Phase II/III trials in cardiovascular disease, diabetes, osteoarthritis, cancer and immune/inflammatory conditions.
Presentations this author is a contributor to:
Investigating the possible roles of HOPX, CMTM8 and ALOX15B during bone marrow mesenchymal stem cell (BMSC) proliferation and cell fate determination in postnatal bone formation (#161)
12:30 PM
Chee Hng
Poster Viewing I (odd numbers)
Inhibition of tyrosine kinase receptor C-ROS-1 as novel treatment in alleviating TWIST-1 haploinsufficiency induced craniosynostosis in children (#48)
11:48 AM
Esther Camp
Proffered papers - Clinical I
The balance of bone homeostasis is disrupted with the loss of ephrinB1 in osteoprogenitors, resulting in an osteoporotic phenotype. (#104)
5:00 PM
Agnieszka Arthur
Welcome Reception & ANZBMS Plenary Posters